by BGA are medical devices used to measure levels of oxygen, carbon dioxide, pH and other electrolytes in a patient’s arterial or venous blood sample. They provide crucial insights into how well the lungs and other organs are functioning by analyzing the gases exchanged in the bloodstream. Measurements from BGA help evaluate patients for conditions like respiratory failure, shock, cardiopulmonary disease and more.
How it work?
BGA use different sensor technologies to measure various parameters from a small blood sample, typically 0.2-1ml. Electrodes are used to detect partial pressure of oxygen (pO2) and carbon dioxide (pCO2), while pH is measured using an ion-sensitive field effect transistor or electrode. Other commonly tested Blood Gas Analyzers include electrolytes like sodium, potassium, calcium and chloride which are assessed using ion-selective electrodes.
Modern BGA are compact benchtop instruments that automatically analyze samples placed in disposable cartridges. The cartridge holds all necessary reagents, electrodes and microfluidic channels required for analysis. Once a sample is inserted, it is transported via microfluidics, mixed with reagents and exposed to sensors for measurement. Results are typically available within minutes and reported directly on the analyzer’s digital display or network.
Role of blood gas analysis in critical care
Blood gas analysis plays a central role in critical care settings like ICUs and emergency rooms. Conditions requiring frequent blood gas monitoring include respiratory distress, shock, trauma, sepsis and other life-threatening illnesses. Measurement of blood gases and acid-base balance help clinicians:
Assess the need for oxygen supplementation or changes to ventilator settings in respiratory failure patients.
Titrate vasopressors and fluids for shock according to oxygen delivery and acid-base balance.
Determine severity and progression of pulmonary and cardiac diseases.
Guide management of COPD, asthma and pneumonia exacerbations.
Evaluate response to therapeutic interventions like diuretics, bronchodilators and corticosteroids.
Rapid turnaround of results from point-of-care blood gas analyzers enables real-time treatment adjustments in critically ill patients. Serial measurements are often required to optimize therapy and monitor patient’s recovery.
Advances in BGA technology
Significant technological advances have made modern BGA faster, easier to use and more versatile compared to previous generation instruments. Some key enhancements include:
Smaller sample volume requirements down to as low as 30μl using microfluidic cartridges, reducing blood loss.
Faster analysis time down to 30 seconds through optimized sensor design and microfluidics.
Automatic calibration checks using integrated calibration cartridges for reliability.
Connectivity options to interface with hospital information systems for streamlined record-keeping.
Built-in quality control functions and audit trails to meet regulatory standards.
Touchscreen interfaces and intuitive software for simplified operation even by occasional users.
Expanding analyte menus to include blood chemistry parameters like lactate and hemoglobin along with standard blood gases.
Portable models suitable for transporting within large hospital premises or point-of-care settings.
Role of blood gas analyzers during COVID pandemic
The COVID-19 pandemic placed enormous strain on critical care resources worldwide. Severe hypoxemic respiratory failure was a hallmark of Advanced COVID pneumonia requiring invasive ventilation support. BGA played a key role in assessing severity of lung involvement, guiding ventilator management and evaluating response to therapies.
Serial measurements aided clinical decision making for: initiation of prone positioning and recruitment maneuvers, steroid therapy and escalation to ECMO if needed. Point-of-care blood gas analysis near patient beds allowed continuous optimization without wasting valuable time transporting samples to central laboratories. Compact portable analyzers were deployed on wheels for bringing testing to patient floors to reduce cross-contamination.
Blood gas analysis has revolutionized critical care practice by enabling real-time assessment of respiration, oxygenation and acid-base balance. Advanced benchtop analyzers with enhanced functionality have streamlined workflow while maintaining high accuracy. Their indispensable role in management of respiratory failure, shock and multiorgan involvement during the COVID pandemic reinforced their significance in modern medical care. Ongoing innovations aim to make blood gas testing more rapid, easy to perform at point-of-care and cost-effective to benefit high-risk patients.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research.
2. We have leveraged AI tools to mine information and compile it.
